May 27, 2013 / 12:17 PM / 5 years ago

CORRECTED-Valeant to buy Bausch & Lomb for $8.7 billion

(Fixes ticker in first line of story)
    TORONTO, May 27 (Reuters) - Valeant Pharmaceuticals
International Inc said on Monday that it had inked an
$8.7 billion cash deal to take over eye health company Bausch &
Lomb Holdings.
    The deal, to be financed through debt and equity, will see
some $4.5 billion go to an investor group led by Warburg Pincus
LLC, with some $4.2 billion used to pay down Bausch & Lomb's
outstanding debt.

 (Reporting by Julie Gordon; Editing by David Cowell)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below